Quoin Pharmaceuticals holds special shareholder meeting

QNRX•2026-11-12

Quoin Pharmaceuticals shareholders approved amendments allowing certain private placement investors to raise ownership limits from 4.99% to no more than 9.99% with written notice.

Quoin Pharmaceuticals holds special shareholder meeting

1. Ownership limits amended

Related News

nLIGHT CEO Scott H. Keeney reports $8.42 million sale of common shares

Snap-on CEO Nicholas T. Pinchuk reports $8.76 million common share disposal

White House weighs Commerce Secretary Lutnick's ouster amid Nvidia export concerns, sources say

Sources

Quoin Pharmaceuticals holds special shareholder meeting

Host Hotels & Resorts enters equity distribution agreement for up to $600 million

Feeder cattle rise on technical buying and weaker corn prices